Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1902484

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1902484

Fecal Occult Testing Market Size, Share, and Growth Analysis, By Test type (Immuno-FOB ELISA Test, Lateral Flow Immuno-FOB Test), By End-User (Hospitals and Clinics), By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Fecal Occult Testing Market size was valued at USD 206.82 Billion in 2024 and is poised to grow from USD 222.12 Billion in 2025 to USD 393.22 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global fecal occult testing market is crucial for detecting hidden blood in stool samples, which is indicative of various medical conditions including colon cancer, polyps, and inflammatory bowel diseases. The demand for this screening method is increasing due to the rising incidence of colorectal cancer, government initiatives promoting awareness, and advancements in medical technology and testing techniques. Despite barriers such as low public awareness and cost concerns, opportunities abound through the rise of direct-to-consumer lab tests and the availability of testing devices online. The market encompasses different product types, such as guaiac FOB, immuno-FOB tests, and is utilized in various clinical settings including hospitals and diagnostic laboratories, with a broad geographical presence across key global regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fecal Occult Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fecal Occult Testing Market Segments Analysis

Global Fecal Occult Testing Market is segmented by Test Type, Application, End-use and region. Based on Test Type, the market is segmented into Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test and Immuno-FOB ELISA test. Based on Application, the market is segmented into Colorectal Cancer, Gastrointestinal Bleeding, Anemia and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is significantly influenced by heightened public awareness surrounding colorectal cancer and the importance of regular screening measures. Efforts such as healthcare initiatives and awareness campaigns encourage both individuals and healthcare professionals to prioritize screening. Additionally, government-sponsored programs and established guidelines promoting routine fecal occult blood testing for specific age demographics contribute to the growing demand for these diagnostic tests. This combination of education and structured recommendations is fostering a more proactive approach to colorectal cancer prevention and detection, thereby boosting the market for fecal occult testing as an essential health measure.

Restraints in the Global Fecal Occult Testing Market

The global fecal occult testing market faces significant challenges related to the potential for false positive and false negative results, which can undermine diagnostic reliability and create patient concern or overconfidence. False positives may lead to unnecessary additional tests or invasive procedures, while false negatives can result in missed diagnoses, further delaying essential treatment. It is vital to address these limitations regarding the sensitivity and specificity of fecal occult blood tests to ensure continued trust in their diagnostic capabilities. By improving the accuracy of these tests, the market can better serve both healthcare providers and patients, ultimately enhancing outcomes and care quality.

Market Trends of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is increasingly leaning towards point-of-care testing, driven by the demand for rapid results and enhanced convenience. This trend emphasizes accessibility in primary care settings, community health clinics, and remote areas with limited laboratory facilities. The development of user-friendly, cost-effective point-of-care fecal occult blood tests presents a significant opportunity to broaden screening and diagnostic services, particularly in resource-constrained environments. As healthcare systems prioritize early detection and preventive measures, the market is poised for growth, fostering innovations that facilitate access and improve patient outcomes across diverse populations.

Product Code: SQMIG35A2892

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Fecal Occult Testing Market Size by Test Type & CAGR (2026-2033)

  • Market Overview
  • Guaiac FOB stool test
  • Immuno-FOB agglutination test
  • Lateral flow immuno-FOB test
  • Immuno-FOB ELISA test

Global Fecal Occult Testing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Colorectal Cancer
  • Gastrointestinal Bleeding
  • Anemia
  • Others

Global Fecal Occult Testing Market Size by End-use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Diagnostic centers
  • Others

Global Fecal Occult Testing Market Size & CAGR (2026-2033)

  • North America (Test Type, Application, End-use)
    • US
    • Canada
  • Europe (Test Type, Application, End-use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Test Type, Application, End-use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Test Type, Application, End-use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Test Type, Application, End-use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Quidel Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wondfo (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eiken Chemical Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biohit Oyj (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meridian Bioscience (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inova Diagnostics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • US Diagnostics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sekisui Diagnostics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Wako Pure Chemical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Helena Laboratories (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Exact Sciences Corp. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!